A 70 year old man with permanent atrial fibrillation is reviewed in clinic. His comorbidities include hypertension and type 2 diabetes. He has no history of stroke, heart failure or vascular disease. He is currently taking aspirin 75 mg daily. His CHA2DS2 VASc score is 3. What is the most appropriate change to his antithrombotic therapy?